Good News for Biolase, Henry Schein Medical Systems

Fun with an Argon-ion and a He-Ne laser. Most ...Image via Wikipedia Big News for Biolase today. Biolase is poised to make a profit now and increase their market cap which is currently, 19.41M.

Biolase has been bleeding cash and losing money this year. Annual Revenue is 43.35M and they reported a loss of 2.96M last year, however that was an improvement from a loss of 8.78M in 2008 and 8.97M in 2007. Revenue has been down from those two years.

In 3 years Biolase's stock has fallen from a high of 8/share to trading today at 0.80. Hopefully, this stock will rebound to its 2007 prices for large profits.

Marketwatch news on Biolase

IRVINE, CA, Aug 30, 2010 (MARKETWIRE via COMTEX) -- BIOLASE Technology, Inc. (BLTI 0.80, +0.19, +31.15%), the world's leading dental laser company, announced today that in addition to the recent strategic and management changes, Executive Chairman and Interim CEO Federico Pignatelli will also discuss its distribution agreement with Henry Schein (HSIC 52.80, -0.38, -0.71%) and the Company's revised direct and multi-distributor strategy going forward on a conference call today, Monday, August 30, at 11:00 a.m. Eastern Time.

More Information about Biolase

About BIOLASE Technology, Inc. BIOLASE Technology, Inc., the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Enhanced by Zemanta

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.